Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Policy / Pricing

Trump Hits Drugmakers With 100% Tariff but Carve-outs Soften the Blow

 April 3, 2026

BioSpace

While some large companies could start paying the full tariff in 120 days, many products, including orphan drugs, cell and gene therapies, and antibody-drug conjugates, will enjoy exemptions that waiv

Policy / PricingRead full story

Post navigation

Pharma’s M&A Train Is on Track for Record Highs With More Deals To Come: Analysts →
← US pharma tariffs of up to 100% finalised by Trump

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com